A335810 Stock Overview
An in-vitro diagnostics company, manufactures, distributes, and sells diagnostic reagents and analyzing devices in South Korea. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Precision Biosensor, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩2,850.00 |
| 52 Week High | ₩6,350.00 |
| 52 Week Low | ₩2,785.00 |
| Beta | 0.50 |
| 11 Month Change | -16.18% |
| 3 Month Change | -28.66% |
| 1 Year Change | -43.45% |
| 33 Year Change | -74.32% |
| 5 Year Change | n/a |
| Change since IPO | -91.23% |
Recent News & Updates
Some Confidence Is Lacking In Precision Biosensor, Inc. (KOSDAQ:335810) As Shares Slide 30%
Sep 10
We Think Precision Biosensor (KOSDAQ:335810) Has A Fair Chunk Of Debt
Aug 26Subdued Growth No Barrier To Precision Biosensor, Inc.'s (KOSDAQ:335810) Price
Jul 02Shareholder Returns
| A335810 | KR Medical Equipment | KR Market | |
|---|---|---|---|
| 7D | -3.4% | 8.1% | 2.9% |
| 1Y | -43.5% | 11.5% | -2.8% |
Return vs Industry: A335810 underperformed the KR Medical Equipment industry which returned 11.7% over the past year.
Return vs Market: A335810 underperformed the KR Market which returned -4% over the past year.
Price Volatility
| A335810 volatility | |
|---|---|
| A335810 Average Weekly Movement | 11.4% |
| Medical Equipment Industry Average Movement | 6.8% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in KR Market | 11.5% |
| 10% least volatile stocks in KR Market | 2.7% |
Stable Share Price: A335810's share price has been volatile over the past 3 months compared to the KR market.
Volatility Over Time: A335810's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of KR stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2015 | 102 | Hanshin Kim | precision-bio.com |
Precision Biosensor, Inc., an in-vitro diagnostics company, manufactures, distributes, and sells diagnostic reagents and analyzing devices in South Korea. The company offers cartridges for cardiac, infection, and brain, as well as colorectal, pregnancy, and vitamin D deficiency indications; and immunochromatographic analyzers. It also provides thermostat devices for activating the reagent reactions; and IQC analyzers.
Precision Biosensor, Inc. Fundamentals Summary
| A335810 fundamental statistics | |
|---|---|
| Market cap | ₩33.10b |
| Earnings (TTM) | -₩6.81b |
| Revenue (TTM) | ₩17.14b |
1.9x
P/S Ratio-4.9x
P/E RatioIs A335810 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A335810 income statement (TTM) | |
|---|---|
| Revenue | ₩17.14b |
| Cost of Revenue | ₩11.99b |
| Gross Profit | ₩5.15b |
| Other Expenses | ₩11.95b |
| Earnings | -₩6.81b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -586.00 |
| Gross Margin | 30.03% |
| Net Profit Margin | -39.72% |
| Debt/Equity Ratio | 52.0% |
How did A335810 perform over the long term?
See historical performance and comparison